- Home
- MRK vs TD Comparison
MRK vs TD Comparison
Compare MRK & TD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | TD |
|---|---|---|
| Founded | 2000 | 1855 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 158.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | TD |
|---|---|---|
| Price | $111.35 | $93.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 1 |
| Target Price | $115.00 | ★ $120.00 |
| AVG Volume (30 Days) | ★ 13.5M | 2.3M |
| Earning Date | 02-03-2026 | 02-26-2026 |
| Dividend Yield | 3.06% | ★ 3.24% |
| EPS Growth | 58.08 | ★ 144.91 |
| EPS | 7.56 | ★ 8.25 |
| Revenue | ★ $64,235,000,000.00 | $45,149,067,348.00 |
| Revenue This Year | $1.98 | N/A |
| Revenue Next Year | $4.94 | $4.29 |
| P/E Ratio | $14.69 | ★ $11.37 |
| Revenue Growth | 1.68 | ★ 18.83 |
| 52 Week Low | $73.31 | $54.14 |
| 52 Week High | $112.90 | $96.44 |
Technical Indicators
Market Signals| Indicator | MRK | TD |
|---|---|---|
| Relative Strength Index (RSI) | 69.24 | 61.45 |
| Support Level | $107.22 | $92.52 |
| Resistance Level | $112.90 | $94.88 |
| Average True Range (ATR) | 2.32 | 1.18 |
| MACD | 0.05 | -0.49 |
| Stochastic Oscillator | 81.46 | 39.81 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks with over CAD 2 trillion in assets. TD Bank operates four business segments: Canadian personal and commercial banking, US retail banking, wealth management and insurance, and wholesale banking. The bank derives more than 50% of its revenue from Canada and has dominant market share in nearly all banking products and services. TD has around 44% of its revenue from its US operations. Its US footprint spans from Maine to Florida, with a strong presence in the Northeast.